Smith & Nephew plc (NYSE:SNN) Receives Average Rating of “Hold” from Analysts

Shares of Smith & Nephew plc (NYSE:SNN) have been given a consensus rating of “Hold” by the five research firms that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company.

Separately, StockNews.com raised Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 15th.

Smith & Nephew Stock Performance

SNN stock opened at $23.88 on Tuesday. Smith & Nephew has a twelve month low of $21.52 and a twelve month high of $33.08. The company has a quick ratio of 0.72, a current ratio of 1.77 and a debt-to-equity ratio of 0.44. The business has a 50 day moving average of $26.06 and a 200 day moving average of $25.96.

Smith & Nephew Dividend Announcement

The firm also recently announced a semi-annual dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Tuesday, April 2nd will be issued a $0.462 dividend. This represents a dividend yield of 2.8%. The ex-dividend date is Monday, April 1st.

Institutional Trading of Smith & Nephew

A number of institutional investors and hedge funds have recently modified their holdings of SNN. Ronald Blue Trust Inc. increased its holdings in shares of Smith & Nephew by 173.9% in the 3rd quarter. Ronald Blue Trust Inc. now owns 3,235 shares of the medical equipment provider’s stock worth $80,000 after purchasing an additional 2,054 shares in the last quarter. Ridgewood Investments LLC boosted its stake in shares of Smith & Nephew by 33.5% in the 3rd quarter. Ridgewood Investments LLC now owns 49,106 shares of the medical equipment provider’s stock worth $1,216,000 after buying an additional 12,316 shares during the last quarter. SVB Wealth LLC boosted its stake in shares of Smith & Nephew by 8.4% in the 3rd quarter. SVB Wealth LLC now owns 12,487 shares of the medical equipment provider’s stock worth $309,000 after buying an additional 970 shares during the last quarter. Intellectus Partners LLC boosted its stake in shares of Smith & Nephew by 15.1% in the 3rd quarter. Intellectus Partners LLC now owns 10,761 shares of the medical equipment provider’s stock worth $267,000 after buying an additional 1,413 shares during the last quarter. Finally, Park Avenue Securities LLC boosted its stake in shares of Smith & Nephew by 14.3% in the 3rd quarter. Park Avenue Securities LLC now owns 26,271 shares of the medical equipment provider’s stock worth $651,000 after buying an additional 3,294 shares during the last quarter. Institutional investors own 25.64% of the company’s stock.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.